fda wegovy - Search News

Order byBest matchMost fresh

News

Wegovy, Novo Nordisk and FDA

FDA Approves Wegovy to Treat Serious Liver Disease

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. About 14.9 million U.S. adults — or roughly 6% of the population — have the condition, according to the FDA.

Continue reading

· 3d · on MSN

Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

BioPharma Dive · 3d

Novo’s Wegovy becomes first GLP-1 drug approved for MASH

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...

Oral Wegovy’s Pending Approval Puts Spotlight on Viability of High-Dose Peptides

While the 10-fold increase in dose over injectable Wegovy has raised questions about the launch, Novo Nordisk has assured ...

2d

US FDA greenlights first glucose monitoring system for weight loss

In a significant development for weight management, the Food and Drug Administration (FDA) announced Wednesday its approval ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results